Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
- Posted on March 19, 2026
- By CNBC
- 6 Views
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.
